Anesthesia, Gout, JIA, and Osteoarthritis Review

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/39

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering anesthesia classes, gout diagnosis and management, pseudogout, juvenile idiopathic arthritis subtypes, and osteoarthritis characteristics based on the lecture notes.

Last updated 2:06 PM on 9/29/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

40 Terms

1
New cards

Anesthesia

Medical procedure performed by administering drugs that cause loss of sensation.

2
New cards

Local Anesthesia

Loss of sensation to a limited part of the body without loss of consciousness, commonly using sodium channel blockers.

3
New cards

Epinephrine (in Local Anesthesia)

Additive to local anesthesia solutions that constricts local blood vessels to prolong the duration of action of the anesthetic.

4
New cards

Esters (Anesthetic class)

The first class of local anesthetics used, such as cocaine.

5
New cards

Amides (Anesthetic class)

Local anesthetics that largely replaced esters because they produce fewer side effects and last longer.

6
New cards

General Anesthesia

Administration of drugs causing loss of sensation to the entire body and loss of consciousness by depressing nervous activity in the brain.

7
New cards

Surgical Anesthesia

Stage of general anesthesia characterized by muscular paralysis, stabilization of cardiovascular and respiratory functions, and slowed eye movements.

8
New cards

Inhaled Anesthetics

Anesthetics that prevent the flow of sodium into neurons in the CNS, delaying nerve impulses and reducing neural activity.

9
New cards

Neuromuscular Blockers

Adjuncts to anesthesia that cause paralysis without loss of consciousness.

10
New cards

Sevoflurane (Ultane)

Volatile ether anesthetic with a sweet smell that acts as a potent bronchodilator, ideal for inhalational induction.

11
New cards

Desflurane (Suprane)

Volatile ether anesthetic with poor blood solubility resulting in rapid onset and offset, requiring a specialized pressurized vaporizer due to its low boiling point.

12
New cards

Isoflurane (Forane)

Volatile ether anesthetic that acts as a potent vasodilator, maintains cardiac output, and suppresses convulsive activities.

13
New cards

Halothane (Fluothane)

Alkane volatile anesthetic that sensitizes the heart to catecholamines and carries a risk of rare but fatal Halothane Hepatitis.

14
New cards

Nitrous Oxide ("Laughing Gas")

Inhalation agent acting via NMDA antagonism that provides analgesia but has a high minimum alveolar concentration (MAC=105%\text{MAC} = 105\%) preventing its use as a sole anesthetic.

15
New cards

Compound A

Nephrotoxic substance formed when Sevoflurane is exposed to certain dehydrated CO2\text{CO}_2 absorbents.

16
New cards

Diffusion Hypoxia

Condition occurring when rapid elimination of N2O\text{N}_2\text{O} dilutes alveolar O2\text{O}_2 and CO2\text{CO}_2.

17
New cards

Etomidate

Intravenous anesthetic that binds GABA receptors to enhance GABA effects, providing cardiovascular stability, but contraindicated in septic shock.

18
New cards

Ketamine

Intravenous NMDA receptor antagonist that produces dissociative anesthesia and potent anesthesia without respiratory depression, while increasing heart rate and cardiac output.

19
New cards

Propofol

Widely used intravenous GABA-enhancing anesthetic with rapid onset and rapid recovery, with potential side effects of respiratory depression and bradycardia.

20
New cards

Thiopental

Intravenous GABA-enhancing anesthetic known for decreasing intracranial pressure.

21
New cards

Malignant Hyperthermia

Fatal hypermetabolic condition triggered by volatile flurane anesthetics; treated with dantrolene.

22
New cards

Gout

Crystal-induced inflammatory arthritis caused by the deposition of monosodium urate crystals in joints and tissues.

23
New cards

Monosodium Urate Crystals

Needle-shaped crystals with negative birefringence under compensated polarized light microscopy, characteristic of gout.

24
New cards

Calcium Pyrophosphate Crystals

Rhomboid-shaped crystals with positive birefringence under compensated polarized light microscopy, characteristic of pseudogout (CPPD disease).

25
New cards

Podagra

Sudden, acute joint pain starting at the first metatarsophalangeal (MTP) joint of the big toe, characteristic of a gout attack.

26
New cards

Tophi

Chalky deposits of sodium urate crystals in joints and tissues seen in chronic tophaceous gout.

27
New cards

Synovial Fluid Needle Aspiration

The gold standard diagnostic method for confirming gout by analyzing joint fluid.

28
New cards

Double Contour Sign

Ultrasound finding in gout demonstrating urate crystals coating cartilage surfaces.

29
New cards

Colchicine

Medication given within 24 hours of gout onset (1.2 mg1.2\,\text{mg} followed by 0.6 mg0.6\,\text{mg} in 1 hour); common side effects include diarrhea, nausea, and vomiting.

30
New cards

Allopurinol

Urate Lowering Therapy (ULT) starting at 50–100 mg50\text{--}100\,\text{mg} daily and titrated over 2--5 weeks to reach serum uric acid levels below 6.0 mg/dL6.0\,\text{mg/dL}.

31
New cards

Septic Arthritis

Joint infection red-flag condition with fever (>100.4∘F>100.4^\circ\text{F}), chills, rigor, and toxic appearance; must be ruled out before treating for gout.

32
New cards

Juvenile Idiopathic Arthritis (JIA)

The most common pediatric rheumatology disease, defined as joint inflammation lasting longer than 6 weeks in patients under age 16.

33
New cards

Systemic JIA

JIA subtype characterized by fever, rash, lymphadenopathy, hepatosplenomegaly, elevated WBC/ferritin, and excellent response to IL-1 and IL-6 inhibitors.

34
New cards

Oligoarticular JIA

JIA subtype affecting 4 or fewer joints, most common in young females (peak age 2–3), frequently positive for low-titer ANA, and highly responsive to methotrexate and TNF inhibitors.

35
New cards

Polyarticular JIA

JIA subtype affecting 5 or more joints in a symmetrical distribution, with peaks at ages 2–5 and 10–14.

36
New cards

Osteoarthritis (OA)

Mechanical joint disorder resulting from breakdown of cartilage and changes to underlying bone due to cumulative joint stress, without systemic symptoms.

37
New cards

Heberden's Nodules

Bony enlargements located at the distal interphalangeal (DIP) joints in osteoarthritis.

38
New cards

Bouchard's Nodules

Bony enlargements located at the proximal interphalangeal (PIP) joints in osteoarthritis.

39
New cards

Crepitus

Crunching sound or feeling during joint movement caused by irregular cartilage surfaces in osteoarthritis.

40
New cards

Duloxetine (Cymbalta)

Pharmacologic treatment for knee osteoarthritis prescribed at 30 mg/day30\,\text{mg/day} for 7 days then increased to 60 mg/day60\,\text{mg/day}.